Suchergebnisse - "Selle, F"

PubPharm (11)

1

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38) : a phase IIIb trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Pujade-Lauraine, E. | Selle, F. | Scambia, G. | +21

CommentOn: Ann Oncol. 2023 Dec;34(12):1074-1076. - PMID 38072509

2

Olaparib plus bevacizumab first-line maintenance in ovarian cancer : final overall survival results from the PAOLA-1/ENGOT-ov25 trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Ray-Coquard, I. | Leary, A. | Pignata, S. | +28

3

Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors : a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von De Giorgi, U. | Richard, S. | Badoglio, M. | +16

4

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma : a stratified type I-type II study from the GINECO group

enthalten in: British journal of cancer | 2017

von Heudel, P. | Fabbro, M. | Roemer-Becuwe, C. | +18

5

A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy : the Multicentric TAXIF II study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Selle, F. | Wittnebel, S. | Biron, P. | +20

CommentIn: Ann Oncol. 2014 Sep;25(9):1679-80. - PMID 25004919

6

Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients

enthalten in: British journal of cancer | 2010

von Fajac, A. | Gligorov, J. | Rezai, K. | +9

7

Rare ovarian tumours : therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France

enthalten in: Bulletin du cancer | 2010

von Ray-Coquard, I. | Pautier, P. | Pujade-Lauraine, E. | +8

8

Standards, Options : Recommendations for the management of patients with epithelial ovarian cancer. Medical front-line treatment (summary report, update 2008)

enthalten in: Gynecologie, obstetrique & fertilite | 2008

von Fédération nationale des centres de lutte contre le cancer (FNCLCC) | Lhommé, C. | Planchamp, F. | +98

9

High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2006

von Pedrazzoli, P. | Ledermann, J. | Lotz, J. | +11

10

Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas : the ITOV 01 protocol

enthalten in: Bone marrow transplantation | 2006

von Lotz, J. | Pautier, P. | Selle, F. | +16